Filing Details

Accession Number:
0001209191-22-053579
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-13 16:57:57
Reporting Period:
2022-10-11
Accepted Time:
2022-10-13 16:57:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX Biological Products, (No Disgnostic Substances) (2836) 464233385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813800 Jeff Fairman C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
Vp, Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-11 5,000 $25.50 296,227 No 4 S Indirect By Fairman Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Fairman Family Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 17,143 Direct
Common Stock 50,000 Indirect By AF 2020 Irrevocable Trust
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.